News

The 6th annual European Antibody Congress 2010

The industry’s largest and most influential monoclonal antibody conference
The 6th annual European Antibody Congress is the World’s leading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic nonoclonal antibody development. Please visit the website for full programme and speaker details. www.terrapinn.com/antibodies
  • New market success stories: golimumab, canakinumab, obatumumab, farletuzmab and girentuximab case studies
  • For the first time on the agenda: Amgen, the FDA, Chugai Pharmaceutical Co, sanofi-aventis, Sandoz, Merrimack
  • Pharmaceuticals, AdAlta, Wilex, Vaccinex and Biocon
  • First ever discussion of global biosimilar antibody development and impact on the European market
  • Exploring radio-immunoconjugates: scientific, technical, regulatory and logistical challenges
15.07.2010 | David Kitz Kramer   RSS Feed   New Antibodies   Bookmark and Share

RSS Feed  More Headlines: New Antibodies

RSS Feed  New Antibodies